Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis

Antonio B Fernandez1, Tien Y Wong, Ronald Klein

  • 1Department of Cardiology, Rhode Island Hospital, Brown University School of Medicine, 593 Eddy Street, Providence, RI 02903, USA. antoinefernandezt@hotmail.com

Ophthalmology
|December 27, 2011
PubMed

Insights

Age-related macular degeneration (AMD) does not appear to increase the risk of coronary heart disease (CHD) or cardiovascular disease (CVD) events. This study found no significant association between AMD and these conditions in a multi-ethnic cohort.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Public Health

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Coronary heart disease (CHD) and cardiovascular disease (CVD) are major global health concerns.
  • The potential link between AMD and cardiovascular risk requires further investigation.

Purpose of the Study:

  • To investigate if age-related macular degeneration (AMD) is an independent risk indicator for coronary heart disease (CHD) and cardiovascular disease (CVD) events.
  • To analyze this association within a diverse, multi-ethnic population.
  • To control for other known cardiovascular risk factors.

Main Methods:

  • A population-based prospective cohort study design was employed.
  • The Multi-Ethnic Study of Atherosclerosis (MESA) included 6233 participants aged 45-84 without prior CVD.
  • Retinal photographs assessed for AMD, with CHD and CVD events tracked over 8 years.

Main Results:

  • No statistically significant difference in incident CHD or CVD was observed between participants with and without AMD.
  • Cox regression models, adjusted for CVD risk factors, showed no significant relationship between AMD and CHD/CVD events.
  • Subgroup analyses of early or late AMD also revealed no significant association with incident CHD/CVD.

Conclusions:

  • Age-related macular degeneration (AMD) was not associated with an increased risk of coronary heart disease (CHD) or cardiovascular disease (CVD) events.
  • This finding holds true for individuals without a prior history of cardiovascular disease.
  • AMD is unlikely to be a predictive biomarker for future cardiovascular events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...